NIH-funded research R01 grant

How a mother's insulin and placenta signaling shape a child's future metabolism

Official title: Placental Insulin Signaling and mTOR Nutrient-Sensing Programming of Offspring Metabolic Health

Funded at University of Minnesota · NIH-11303252 · Data updated 2026-11-12

This work looks at how high insulin in pregnant people changes the placenta and may raise their children's risk for Type 2 diabetes later in life.

More Metabolic Health research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startMarch 1, 2023
Project endFebruary 28, 2027
Funding year2026
Award (this year)$521,795
NIH project number5R01DK136237-04
Project IDNIH-11303252 on NIH RePORTER

Who could benefit from this research

Could help

People who were pregnant with high insulin levels (for example, with prediabetes, obesity, or gestational diabetes) and their children would be the most relevant candidates for related studies or future trials.

Less likely to help

People without a history of maternal hyperinsulinemia or those seeking immediate treatments for existing Type 2 diabetes may not see direct benefit from this specific mechanistic research.

What this research studies

This research follows how a mother's high insulin during pregnancy changes placental signaling and nutrient supply to the fetus. Researchers use laboratory models and genetic tools to see how those placental changes alter offspring weight and blood sugar over time. The team has preliminary data from animal models showing offspring of hyperinsulinemic mothers gain weight and develop glucose problems, and that changing placental insulin signaling can help. Findings aim to point to new ways to prevent diabetes that starts from pregnancy exposures.

Why it matters

Potential benefit: If successful, the work could reveal placental mechanisms that lead to diabetes risk and suggest ways to prevent metabolic disease in children of hyperinsulinemic pregnancies.

How similar studies have gone: Prior animal studies and the investigators' preliminary data show altered offspring metabolism from maternal hyperinsulinemia and that changing placental insulin signaling can improve outcomes in models, but human translation is still early.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Alejandro, Emilyn — University of Minnesota
  • Study coordinator: Alejandro, Emilyn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.